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http://www.jbiomedsci.com/content/20/1/70RESEARCH Open AccessIn silico characterization of a novel pathogenic
deletion mutation identified in XPA gene in a
Pakistani family with severe xeroderma
pigmentosum
Muhammad Nasir1, Nafees Ahmad1, Christian MK Sieber2, Amir Latif3, Salman Akbar Malik4 and Abdul Hameed1*Abstract
Background: Xeroderma Pigmentosum (XP) is a rare skin disorder characterized by skin hypersensitivity to sunlight
and abnormal pigmentation. The aim of this study was to investigate the genetic cause of a severe XP phenotype
in a consanguineous Pakistani family and in silico characterization of any identified disease-associated mutation.
Results: The XP complementation group was assigned by genotyping of family for known XP loci. Genotyping
data mapped the family to complementation group A locus, involving XPA gene. Mutation analysis of the candidate
XP gene by DNA sequencing revealed a novel deletion mutation (c.654del A) in exon 5 of XPA gene. The c.654del A,
causes frameshift, which pre-maturely terminates protein and result into a truncated product of 222 amino acid (aa)
residues instead of 273 (p.Lys218AsnfsX5). In silico tools were applied to study the likelihood of changes in structural
motifs and thus interaction of mutated protein with binding partners. In silico analysis of mutant protein sequence,
predicted to affect the aa residue which attains coiled coil structure. The coiled coil structure has an important role
in key cellular interactions, especially with DNA damage-binding protein 2 (DDB2), which has important role in
DDB-mediated nucleotide excision repair (NER) system.
Conclusions: Our findings support the fact of genetic and clinical heterogeneity in XP. The study also predicts the
critical role of DDB2 binding region of XPA protein in NER pathway and opens an avenue for further research to
study the functional role of the mutated protein domain.
Keywords: Genetic skin disorder, Novel mutation, Nucleotide excision repair, Xeroderma pigmentosum, XPABackground
Xeroderma Pigmentosum (XP) is one of the rare auto-
somal recessive inherited skin disorders. The incidence
of the disease is 1 in 20,000 to 1 in 250,000 births in
Japan and USA respectively and, approximately 2.3 per
million live births in Western Europe has been reported
[1,2]. XP was first described by Hebra and Kaposi in
1874 [3]. The disorder is characterized by extreme sensi-
tivity to sunlight which leads to high incidence of skin
sunburn, pigmentary changes, skin dryness and frequent
neurological abnormalities. The UV exposed areas of the* Correspondence: ahameed0786@hotmail.com
1Institute of Biomedical and Genetic Engineering, 24-Mauve area, G-9/1,
Islamabad 44000, Pakistan
Full list of author information is available at the end of the article
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reproduction in any medium, provided the orskin, tongue and eye have a high cancer risk [4,5]. XP
can result from mutation in any one of the eight XP
genes (XPA-XPG and XPV) and affects both gender, and
all races across the continents [6]. Although XP genes
have different chromosomal locations and code for eight
different proteins; however, all are involved in the repair
of ultraviolet (UV)-induced damages in DNA. Based on
involvement of eight different genes and their protein
products, XP has been sub-categorized into seven com-
plementation groups plus one variant form (XP-A-XP-G
and a variant XP-V) [7,8]. Out of eight, seven gene prod-
ucts (XPA-G) are required for the removal of UV-
damaged part of the DNA while the eighth (XPV), a
variant form, is required for the replication of DNA
containing unrepaired damage [6,9]. Any pathogenicd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Nasir et al. Journal of Biomedical Science 2013, 20:70 Page 2 of 8
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cell stability of UV-induced DNA repair and prone them
to the lethal and mutagenic effects of UV radiation dam-
age [10]. However, severity of the disease depends on the
gene involved, site of mutation and residual activity of the
gene. Therefore, a wide variability in clinical features exists
both between and within XP groups [6,11].
Generally, patients with XP complementation group A
show the most severe clinical symptoms of skin and
neurological abnormalities and in most cases, patients
survive till their second or third decade [12]. Tanaka
et al. were the first to map XPA gene on chromosome
9q and characterized this gene [13]. Human XPA gene
consists of 6 exons distributed over ~25 kb of genomic
DNA and encodes 273 aa. XPA is required for UV-
induced DNA damage verification and confirmation that
other NER proteins are in correct position before nucle-
ases cut on either side of the damage [6].
In this study, we have identified a two generational
Pakistani family suffering from XP. All the patients
exhibited signs and symptoms of varying degree depend-
ing on age, sunlight exposure and elevated possibility to
develop basal and squamous cells carcinoma. To find
out the underlying molecular basis of XP, genetic ana-
lysis was carried out and we have identified a novel
homozygous deletion mutation in exon 5 of XPA gene in
this Pakistani family.
Methods
Sample collection and DNA extraction
A consanguineous Pakistani family with severe clinical
skin symptoms was ascertained from Rawalpindi district,
Pakistan. Three individuals, ages 2–5 years in the family
were affected. Detailed clinical examination of all the
family members including affected individuals and their
carrier parents was carried out by a dermatologist in
Rawalpindi. All the affected individuals were presented
with severe clinical skin symptoms of XP. Blood sam-
ples were collected from all the affected and normal
family members. Blood samples were also collected
from 100 ethnically-matched unrelated normal individ-
uals and used as a control for allele frequency calcula-
tion and confirmation of disease-associated mutation.
Genomic DNA for linkage analysis was extracted from
peripheral blood by standard phenol–chloroform DNA
extraction procedure [14]. The study was approved by
institutional ethnic committee (Ethical Committee,
IB&GE, Islamabad, Pakistan) and was in concordance
with the Helsinki declaration.
Genotyping
Polymerase chain reaction (PCR)-based linkage analysis
using microsatellite markers was used for the genotyping
of genomic DNA of the family members. In eachreaction 80 ng of genomic DNA was amplified in 10 μl
final reaction volume using standard PCR protocol. Amp-
lification was performed with an initial denaturation for
5 min at 94°C, followed by 35 cycles of denaturation at
94°C for 45 sec, annealing at 55°C for 45 sec, extension at
72°C for 45 sec and a final extension at 72°C for 10 min.
The PCR product was separated on 8% non-denaturing
polyacrylamide gel stained with ethidium bromide and al-
leles were assigned by visual inspection.
Mutation analysis
For mutation analysis, six pairs of intronic primers were
used to amplify coding DNA sequences of XPA gene.
250 ng of genomic DNA in 50 μl final reaction volume
was amplified using standard PCR protocol. The amplifi-
cation conditions were; 95°C for 5 min, followed by
35 cycles at 95°C for 45 sec, primer-specific annealing
temperature for 45 sec, 72°C for 45 sec and a final ex-
tension at 72°C for 10 min. 10 μl of the PCR products
were analysed on 2.5% agarose gel and remaining PCR
products were purified using QIAquick PCR Purification
Kit (Qiagen, U.K.) and sequenced directly using Big
Dye®Terminator v3.1 cycle sequencing kit on an ABI
3130 genetic analyzer (Applied Biosystems, U.S.A.). Po-
tential disease-associated mutation was confirmed by bi-
directional sequencing, allele specific-PCR and by
assessing 100 control samples having ethnic back-
grounds matching the patients. Sequences were com-
pared with the NCBI reference sequence [NG_011642.1]
and sequence data from this study have been deposited
in GenBank [Accession No. KC899693].
Tetra amplification refractory mutation system (tetra
ARMS-PCR)
Two inner mutation specific ARMS-PCR primer (5′-CG
AGAAAAAATGAAACA GAAGAAA-3′and 5′-GAGA
AAAAATGAAACAGAAGCAA-3′) were designed to ver-
ify the identified deletion. Two outer primers (5′-CAT
TCTTTGGTACCTTTGGA-3′ and 5′-GTAAAACACAA
TCCTTCACG-3′) and one inner primer were used in sin-
gle reaction to amplify exon 5. ARMS-PCR reaction was
carried out in 25 μl final volume containing 200 ng gen-
omic DNA and 1 U Taq DNA polymerase. Amplification
was performed with an initial denaturation for 5 min at
95°C, followed by 35 cycles of denaturation at 95°C for
45 sec, primer-specific annealing temperature for 45 sec,
72°C for 45 sec and a final extension at 72°C for 10 min.
PCR products were analysed on 2% agarose gel and geno-
types were assigned on visual examination.
In silico analysis
To study the effect of deletion mutation on the coding
nucleotide sequence and its impact on the protein
product of XPA gene, CLC workbench 6.6.2 software
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[15] for the comparative secondary structure prediction
of wild-type and mutated protein sequence in combin-
ation with ncoils [16] in order to determine coiled coil
structures. The prediction of intrinsically disordered re-
gions done by globplot [17], sections of low complexity
were determined using seg algorithm [18]. Long dis-
tance interactions due to disulfide bonds that might
contribute to protein structure stability were predicted
by DIANNA [19]. For the localization of functional
domains we scanned for Interpro [20] domains and
Prosite [21] patterns.
The prediction of tertiary structure has been performed
by phyre2 [22] and 3djigsaw [23] algorithms. Super-
positioning of wild-type and mutated structure was done




All the patients possibly affected by birth as the symp-
toms of the disease appeared in the first year of their life.
The affected individuals had very severe clinical symp-
toms of XP that include severe sunburn, blisters,
freckles, irregular pigmentary macules of varying sizes,
atrophy, dryness, ulcers on different body parts with
possible risk to develop basal cells carcinoma (BCC) and
squamous cells carcinoma (SCC). However, no ocular
and neurological involvement was observed in any of
the affected individual (Figure 1). In XPA patients the
appearance of more severe clinical sign and symptoms,Figure 1 A two generation Pakistani family suffering from severe ma
A. Patients ages ranging from 2–5 years (A) patient IV:1 in pedigree; pigme
on nose (may possibly BCC), ulcer on lips & below left eye covered with sc
hypo-pigmentation, dry skin pigmentary macules, ulcer with thread like irre
IV:3 in pedigree; pigmentary macules, hypo-pigmentation, atrophy, dryness
on right ear as well. (D, E) patient IV:2 in pedigree; Ulcer with irregular mar
be SCC.such as neurological involvement is reported to be pro-
gressive. It is therefore, premature to say anything about
the neurological involvement of the disease in patients
investigated because of their young ages. Further, the pa-
tient III: 8 and III: 9 (Figure 2A), which belongs to a su-
perior generation than the patients studied would have
added more to clinical details, such as neurological man-
ifestations of the disease. Unfortunately, both the pa-
tients were not available for inclusion in this study.
Genotyping
Genotyping of affected family members and their carrier
parents (Figure 2A) was carried out using PCR-based
linkage analysis. Genotyping analysis revealed an evi-
dence of linkage with microsatellite markers; D9S301,
D9S303, D9S924, and D9S167 at 9q22.3. All the micro-
satellite markers mentioned above were fully informative
and homozygous in all the affected individuals. The re-
sults were therefore, consistent with the recessive mode
of segregation of the disease in this family. The mapped
region of homozygosity at locus 9q22.3 harbors previ-
ously reported XP associated XPA gene [13].
Mutation screening of XPA gene
Direct DNA sequencing of PCR products from exon 5
revealed a novel homozygous deletion in the XPA coding
sequences at nucleotide position 654 (c.654 del A). All
the affected individuals of the family were homozygous
for this deletion, whereas both the normal parents were
heterozygous for the mutation (Figure 2B). However, de-
letion was not observed in any control samples.nifestations of xeroderma pigmentosum complementation group
ntary macules of varying sizes, atrophy, dryness, scaring, cheilitis, ulcer
ab & hyperkeratosis (B) patient IV:2 in pedigree; marked atrophy with
gular margin on nose with possible risk to develop BCC (C) patient
, ulcer above upper lips, ulcer and pigmentary changes with atrophy
gin with peripheral atrophy and pigmentary changes may possibly
Figure 2 The XP family pedigree and DNA sequence analysis. (A) A multi-generation consanguineous Pakistani family in which XP is
segregating as an autosomal recessive trait. Three affected individuals (IV-1, IV-2, IV-3) and two carrier parents (III-1, III-2 were analysed. (B) Direct
sequencing of the PCR product amplified from exon 5 of XPA gene, revealed an adenine base deletion at position 654 (c.654 del A). The affected
individuals are homozygous for this deletion (arrow), while the parents are heterozygous (carriers) having a normal allele as well as a mutant
allele. (C) ARMS-PCR analysis also showed a heterozygous condition of both normal carrier parent and homozygous condition of all 3
affected individuals.
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bands of sizes 251 bp and 84 bp in both heterozygous
carrier parents while only one band was observed in
all patients homozygous for the deletion mutation
(Figure 2C). ARMS-PCR analysis of exon 5 of XPA gene
showed that the mutant allele co-segregate with the dis-
ease phenotype in the family.
Evaluation of deletion mutation
Mutation analysis using CLC workbench 6.6.2 software
(http://www.clcbio.com/) revealed that adenine deletion
at nucleotide 654 has altered the Lys/K-218 codon
(AAA) to an Asn/N-codon (AAT) and resulted in down-
stream premature termination of XPA protein at amino
acid 222.
Comparative modeling of protein
A comparative analysis of sequence and structure fea-
tures reveals the consequences of the point mutation
in the resulting protein. Predicted secondary structures
showed that the mutated amino acid is located in a
coiled coil alpha helix and causes an interruption of
the structure.
Alignments of Interpro- and Prosite-motifs show that
the coiled coil alpha helix is part of the domain that is
responsible for DNA binding. Despite the shorter struc-
ture in the mutated protein, the binding domain is lo-
cated around 20 residues from the C-terminal end. Thesame holds for the other XPA specific domains. A main
difference is one predicted cAMP- and cGMP-dependent
protein kinase phosphorylation site that is only present in
the wild-type c-terminal region.
Furthermore, in this region two disulfide bonds are lo-
cated. DIANNA detected in total three bonds in the WT
structure between CYS-153, CYS-261 and CYS-129,
CYS-264 as well as between CYS-108, CYS-126. A dif-
ferent binding pattern is predicted in the mutated struc-
ture. Here the cysteins 105 and 153 as well as 108 and
126 form disulfide bonds (Figure 3).
We utilized two algorithms for tertiary structure pre-
diction. Both predictions show conserved structures in
the core region between residues 99 and 210 while the
terminal regions differ strongly from each other. How-
ever, both predictions show a difference in angle of the
coiled coil alpha helix in the mutated structure com-
pared to the wild-type. The conserved region corre-
sponds to the experimentally determined Protein Data
Bank (PDB) structure 1XPA (Figure 4).
Discussion and conclusions
Xeroderma pigmentosum is a genetically heterogeneous
skin disorder and among its eight complementation
groups, XPA form is the most frequent worldwide [11].
To date, more than 30 mutations have been reported in
different functional domains of XPA gene (Additional
file 1: Table S1), which is an indicative of wide genetic
Figure 3 Comparison of predicted sequence and structure features between wild-type and mutant XPA protein. Secondary structure is
depicted as green (alpha-helices) and orange (beta-sheets) boxes. Prediction of coiled coil regions is shown as grey bar. Red diamonds indicate
cysteins involved in disulfide bonds, whereas dashed connections show predicted bonds between them. Blue boxes indicate regions of
functional domains determined by Interpro and Prosite. Prosite Pattern: PS_1: Protein kinase C phosphorylation site, PS_2: XPA protein signature
1, PS_3: XPA protein signature 2, PS_4: Casein kinase II phosphorylation site, PS_5: cAMP- and cGMP-dependent protein kinase phosphorylation
site, PS_6: N-myristoylation site. Interpro-Domains: IPR_1: DNA binding domain, putative, IPR_2: Zinc finger, XPA-type, conserved site, IPR_3:
XPA-type C-terminal, IPR_4: XPA conserved site.
Nasir et al. Journal of Biomedical Science 2013, 20:70 Page 5 of 8
http://www.jbiomedsci.com/content/20/1/70variability across this gene and high level of clinical het-
erogeneity [12]. Several research articles have concluded
that the severity of clinical symptoms depend on the site
of mutation in XPA gene and the residual activity of the
mutated XP protein. Therefore, as we move from N ter-
minal (5′ end) towards C terminal (3′ end) the severity
of clinical manifestations decreases, except in cases where
splice site mutations allow synthesis of small amount of
normal protein [25].
Here we studied a consanguineous Pakistani family
with severe clinical symptoms of XP and identified a
novel homozygous deletion mutation in exon 5 of XPA
gene. Deletion mutation not only led to a shift in the
DNA frame but also resulted in premature termination
of XPA protein translation just 5 residues downstream
from the point of deletion. Hence, resulted premature
truncated XPA protein consists of 222 aa instead of
normal 273 aa (p.Lys218AsnfsX5). The presence of dele-
tion mutation in homozygous condition in all the pa-
tients, heterozygous condition in both normal carriersand its absence in all unrelated 100 controls confirms
disease association of this novel deletion with XP in
Pakistani family.
Analysis of the sequences and their structural features
shows that the mutation interrupts a coiled coil alpha
helix that is part of the functional domain for DNA
binding. According to the sequence alignment of the
Interpro motif, the mutated part of the helix is not in-
volved in the bidding process; anyhow binding affinity of
the whole helix might be affected due to the interrup-
tion. The XPA-functional domains are present in both
wild-type and mutant proteins and are located in the
core region with the highest structure conservation
compared to 1XPA structure.
Another main difference of the two structures is the
predicted disulfide-binding pattern. In the wild-type pro-
tein three disulfide bonds are predicted. One bond is
located in the part not affected by the mutation and can
therefore be found in both proteins, whereas in the
other two cysteins from the unique part are involved
Figure 4 Superimposed tertiary structure of 1XPA and predictions of wild type and mutant XPA protein. 1XPA PDB-structure is illustrated
in yellow. Predictions of the full wild-type and mutated protein is depicted in blue and red, respectively. The mutated site and its pendant in
wild-type are indicated by arrows.
Nasir et al. Journal of Biomedical Science 2013, 20:70 Page 6 of 8
http://www.jbiomedsci.com/content/20/1/70and thus only exist in the wild-type. The residue CYS-
153 is bound in both cases but connected to different
cysteins. These differences in long term interactions
might affect the stability of the protein and contribute to
differences in the tertiary structure.
Super-positioning of the predicted structures and the
experimentally determined PDB structure 1XPA shows
that the core region between residues 99 and 210 is similar
in terms of three-dimensional structure whereas the
C- and N-terminal parts differ strongly from each other.
Explanations might be different binding pattern of disul-
fide bonds, or problems of the algorithm in modeling theFigure 5 Schematic presentation of XPA protein with distinct function
location of the nuclear localization signal (NLS) and the zinc finger motif ar
*Deletion mutation identified in this study. ** Predicted Coiled coil structurstructure due to missing templates and a lot of loop- and
turn-structures in the N-terminal region. The three di-
mensional position of the shorter coiled coil alpha helix
differs in both predictions what might also be a hint for a
different binding affinity of the protein. The predicted
cAMP- and cGMP-dependent protein kinase phosphoryl-
ation site, which is missing in the mutated protein might
play a role in activation or inhibition of the protein.
To establish genotype/phenotype correlation of XP in
Pakistani family, different functional regions of XPA
and its interacting proteins were considered. Different
domains of XPA play a unique role in NER reactional domains. Regions for binding to RPA, ERCC1, DDB2, TFIIH and
e shown. Numbers refer to amino acid numbers for the XPA protein.
e formation region.
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sion repair cross complementing group 1(ERCC1),
DNA damage-binding protein 2 (DDB2), transcription
factor II H (TFIIH) and as well as to UV- or chemical
carcinogen-damaged DNA [26,27]. Our results clearly
show that the deletion identified is present in the central
DNA binding domain of the XPA that span from resi-
dues M98-F219 (Figure 5). DNA binding domain is one
of the major functional regions of XPA protein that pref-
erentially bind to the damaged DNA [28,29]. Mutation
in this crucial region might have altered the binding cap-
acity of XPA protein to the damaged DNA, as predicted
by using in silico tools. Secondly, among the interacting
proteins DDB2 plays a key role in DNA repair by mak-
ing physical interaction with residues 185–226 in XPA
and initiate DDB-mediated NER reaction (Figure 5).
Changes in this region has been reported to decrease the
interaction between XPA and DDB2 [28,30]. Therefore,
we can suggest that nucleotide deletion we found in this
region might have altered the interaction between XPA
and DDB2 and, resulted in inability of cells to carry out
efficient repairing of UV-induced DNA damages. Third
aspect of the condition, where deletion found in codon
218 causes the termination of translation at codon 222
that resulted in complete elimination of exon 6 from the
translated protein (Figure 5). Exon 6 interacts with tran-
scription factor TFIIH, a component of NER complex
formed at DNA damaged site, and play an important
role in DNA repair [28]. Therefore, possible explanation
for severe clinical manifestations of XP in Pakistani fam-
ily, other than prolonged sunlight exposure, might be
the result of complete loss of exon 6 function or deletion
mutation in exon 5 itself might have altered or com-
pletely abolished the capability of XPA protein to inter-
act with damaged DNA and DDB2 protein.
In a nutshell our results suggest that the 3′ half of exon
5 from 207–222aa may play an important accessory role
in DNA binding and retain a significant and clinically im-
portant residual function in DNA repair. The expression
studies of mRNA and protein in clinical samples of pa-
tients would have been supportive to assure the relevance
of in silico predictions of mutant protein and its correl-
ation with clinical manifestation of the disease. Unfortu-
nately, the fresh clinical samples were not available any
more to conduct expression and functional studies as
mentioned in the results section.
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